Browse 133 sickle cell clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
Filter
1
Filter results
Results: 133
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
for
Sickle Cell Disease
Location: Augusta GA
Sponsor: Abdullah Kutlar
Sex: All
Age: 18+
Code: NCT01245179
Phase1, Recruiting
Investigation of the Genetics of Hematologic Diseases
for
Bone Marrow Failure Syndromes, Erythrocyte Disorder,
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 0+
Code: NCT02720679
Recruiting
Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease
for
Sickle Cell Disease, Vaso-occlusive Pain Episode
Location: Washington D.C. DC
Sponsor: Suvankar Majumdar
Sex: All
Age: 4 - 21
Code: NCT06635902
Phase2, Recruiting
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
for
Sickle Cell Disease, Vaso-occlusive Crisis
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 6 - 25
Code: NCT03353584
Recruiting
Cerebral Oxygen Metabolism in Children
for
Sickle Cell Disease, Cerebral Stroke
Location: St Louis MO
Sponsor: Washington University School of Medicine
Sex: All
Age: 3 - 50
Code: NCT04157179
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Genotype -Phenotype Correlation of PKLR Variants With Pyruvate Kinase, 2,3-Diphosphglycerate and Adenosine Triphosphate Activities in Red Blood Cells of People With Sickle Cell Disease
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Sex: All
Age: 18 - 70+
Code: NCT03685721
Recruiting
Relationship Between Abnormal Myocardial Perfusion and Diastolic Dysfunction in Sickle Cell Disease Using PET
for
Sickle Cell Disease
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 18 - 21
Code: NCT05583721
Phase2, Recruiting
A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease
for
Sickle Cell Disease
Location: Chicago IL
Sponsor: EpiDestiny, Inc.
Sex: All
Age: 18+
Code: NCT04055818
Phase1, Recruiting
A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)